Hop­ing to turn CD47 around with Keytru­da com­bo, ALX On­col­o­gy re­ports two Phase 2 fail­ures

5 weeks ago
R&D

New fund will pres­sure flail­ing biotechs, as in­vestor frus­tra­tion boils over

5 weeks ago
Financing
Deals

Lil­ly asks EU reg­u­la­tor to re­vis­it Kisun­la; CHMP rec­om­mends PTC's PKU drug

5 weeks ago
News Briefing

Ab­b­Vie's im­munol­o­gy fran­chise re­mains a pow­er­house, as Skyrizi, Rin­voq com­bine for $5B

5 weeks ago
Pharma

Paul Stof­fels on re­tir­ing from Gala­pa­gos; Boehringer In­gel­heim switch­es up lead­er­ship

5 weeks ago
Peer Review

Mer­ck KGaA clos­es in on Spring­Works deal at $3.5B price point

5 weeks ago
Deals
Pharma

Gilead­'s strong HIV busi­ness bal­ances out low Covid and can­cer drug sales

Last month
Pharma

Cari­bou lays off 32% of staff, cuts lu­pus cell ther­a­py pro­gram be­fore first pa­tient

Last month
People
R&D

Mer­ck is ‘well-po­si­tioned’ on Keytru­da ahead of threat­ened phar­ma tar­iffs, CEO says

Last month
Pharma

On­ly two-thirds of FDA-ap­proved biosim­i­lars have launched, re­port finds

Last month
Pharma
FDA+

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Last month
China
Pharma

Cas­sidy urges con­gres­sion­al re­forms to 340B drug dis­count pro­gram af­ter in­ves­ti­ga­tion

Last month
Pharma
FDA+

Halozyme sues Mer­ck, al­leg­ing in­jectable Keytru­da will in­fringe its patents

Last month
Pharma
Law

The po­ten­tial of all-AI labs

Last month
Health Tech

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Last month
Deals
Pharma

Lotte Bio launch­es ADC ser­vices; Yp­somed to fo­cus on self-in­jec­tion busi­ness

Last month
Manufacturing

Avidi­cure's $50M seed round; Flag­ship's new AI com­pa­ny that de­tects dis­ease

Last month
News Briefing

Ver­san­t's lat­est biotech fo­cus­es on in­flam­ma­to­ry dis­eases

Last month
Financing
Startups

Bris­tol My­er­s' tran­si­tion moves for­ward as it rais­es 2025 rev­enue fore­cast

Last month
Pharma

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

Last month
China
Pharma

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Last month
Pharma

Mer­ck’s Gar­dasil sales sink fur­ther amid Chi­na mar­ket pres­sure

Last month
China
Pharma

Sanofi's Al­tuvi­i­io clos­ing in on block­buster sta­tus, Dupix­ent sales surge

Last month
R&D
Pharma

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Last month
Deals
Pharma
First page Previous page 10111213141516 Next page Last page
A service from the Financial Times